Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | arachidonate 5 lipoxygenase | 0.0055 | 0.3417 | 0.3877 |
Loa Loa (eye worm) | AGC/GRK/GRK protein kinase | 0.0124 | 1 | 1 |
Echinococcus granulosus | [G-protein-coupledreceptor] kinase | 0.0111 | 0.8813 | 1 |
Schistosoma mansoni | lipoxygenase | 0.0055 | 0.3417 | 0.3417 |
Echinococcus multilocularis | arachidonate 5 lipoxygenase | 0.0055 | 0.3417 | 0.3877 |
Plasmodium falciparum | LCCL domain-containing protein | 0.002 | 0 | 0.5 |
Onchocerca volvulus | 0.002 | 0 | 0.5 | |
Onchocerca volvulus | 0.002 | 0 | 0.5 | |
Echinococcus multilocularis | G protein coupled receptor kinase 6 | 0.0111 | 0.8813 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0124 | 1 | 1 |
Plasmodium vivax | multidomain scavenger receptor, putative | 0.002 | 0 | 0.5 |
Brugia malayi | Probable G protein-coupled receptor kinase F19C6.1, putative | 0.0111 | 0.8813 | 0.8813 |
Loa Loa (eye worm) | AGC/GRK/GRK protein kinase | 0.0111 | 0.8813 | 0.8813 |
Loa Loa (eye worm) | G protein-coupled receptor kinase 1 | 0.0111 | 0.8813 | 0.8813 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (functional) | > 80 % | Antiinflammatory activity in mouse BV2 cells assessed as inhibition of LPS-induced NO production at 50 uM after 24 hrs by Griess assay relative to control | ChEMBL. | 24042007 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.